Boehm U, Bouloux P-M, Dattani MT, de Roux N, Dode C, Dunkel L, Dwyer AA, Giacobini P, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism – pathogenesis, diagnosis and treatment. Nature Reviews Endocrinology, 2015, 11: 547–564.
Райгородская Н.Ю. Мини-пубертат у здоровых мальчиков и мальчиков с репродуктивной патологией (обзор литературы). Сборник научных трудов НИИ фундаментальной и клинической уронефрологии Саратовского ГМУ им. В.И. Разумовского «Актуальные проблемы фундаментальной и клинической уронефрологии. 2015». Урология ID: 2015-061276-R-5310.
Han TS, Bouloux PM.. What is the optimal therapy for young males with hypogonadotropic hypogonadism? Clin Endocrinol (Oxf), 2010, 72: 731–7.
Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y, et al.Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J, 2012, 59: 1099–105.
Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag, 2009, 5: 427–4.
Majzoub A and Sabanegh E, Jr. Testosterone replacement in the infertile man. Transl Androl Urol, 2016 Dec, 5(6): 859–865.
Shoskes JJ, Wilson MK, Spinner ML. Pharmacology of testosterone replacement therapy preperations. Translation Andrology and Urology, 2016, 5(6) 834-843.
Dwyer AA, Sykiotis GP, Hayes FJ, Boepple PA, Lee H, Loughlin KR, et al. Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab, 2013, 98: E1790–5.
Sato N, Hasegawa T, Hasegawa Y, Arisaka O, Ozono K, Amemiya S, Kikuchi T, Tanaka H, Harada S, Miyata I, Tanaka T. Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols. Clin Pediatr Endocrinol, 2015 Apr, 24(2):37-49.
Drobac S, Rubin K, Rogol AD, Rosenfield RL. A workshop on pubertal hormone replacement options in the United States. J Pediatr Endocrinol Metab, 2006, 19: 55–64.
Ramaswamy S, Weinbauer GF. Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone. Spermatogenesis, 2014, 4(2):e996025.
Valdes-Socin H, Salvi R, Daly AF, Gaillard RC, Quatresooz P, Tebeu P-M, et al. Hypogonadism in a Patient with a Mutation in the Luteinizing Hormone Beta-Subunit Gene. Engl J Med, 2004, 351: 2619-2625.
Rohayem J, Hauffa BP, Zacharin M, Kliesch S, Zitzmann M, and the “German Adolescent Hypogonadotropic Hypogonadism Study Group”a. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence. Clinical Endocrinology, 2016, 10: 1–13.
Pendergast MK. Regulatory Agency Consideration of Pharmacogenomics. Volume: 233 issue: 12, page(s): 1498-1503 Article first published online: August 21, 2017, Issue published: December 1, 2008. https://doi.org/10.3181/0806-S-207..
DOI: 10.3181/0806-S-207
Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian J Androl, 2016 May-Jun, 18(3): 435–440. doi: 10.4103/1008-682X.173932..
DOI: 10.4103/1008-682X.173932
Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM, Skakkeb.k NE, Juul A. Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab, 2010 Dec, 95(12):5357-64.
Aksglaede L, Olesen IA, Carlsen E, Petersen JH, Juul A, Jorgensen N. Serum concentration of anti-Mullerian hormone is not associated with semen quality. Andrology, 2018 Mar, 6(2): 286292.
Chemes HE, Rey RA, Nistal M, Regadera J, Musse M, Gonzalez-Peramato P, Serrano A. Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J Clin Endocrinol Metab, 2008 Nov, 93(11): 4408-12.
Rey RA, Musse M, Venara M, Chemes HE. Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microsc Res Tech, 2009 Nov, 72(11):787-95.
Alfano M, Ventimiglia E, Locatelli I, Capogrosso P, Cazzaniga W, Pederzoli F, Frego N, Matloob R, Sacca A, et al. Anti-Mullerian Hormone-toTestosterone Ratio is Predictive of Positive Sperm Retrieval in Men with Idiopathic NonObstructive Azoospermia. Scientific Reports, 2017, 7: 17638.
Руководство по детской эндокринологии. Под ред. Чарльза Г.Д. Брука, Розалинд С. Браун: пер. с англ. Под ред. В.А. Петерковой. М.: ГЭОТАР-Медиа, 2009. 352 с.
Ring J, Welliver C, Parenteau M, Markwell S, Brannigan RE, Kohler TS. The Utility of Sex Hormone-Binding Globulin in Hypogonadism and Infertile Males. J Urol, 2017 May, 197(5): 1326-1331.